First Trust Indxx MeddevMDEVETF
13F holders, Q2 2024 (June 30)7holders +1
2new positions
1sold out
$19.87avg. 13F price*
At the end of Q2 2024, 7 institutions reported holding First Trust Indxx Meddev (MDEV) in their 13F filings, up 1 from Q1 2024. 2 opened new positions and 1 sold out. The largest holders were Glenview Trust Co ($732K), Arax Advisory Partners ($475K) and Jane Street Group, LLC ($293K).
- Company
- First Trust Indxx Meddev
- CUSIP
- 33738R639
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $302K |
| Exits | 1 | $238K |
All 13F filers, Q1 2024 → Q2 2024: 16,729 shares bought and 12,579 shares sold, net +4,150 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Glenview Trust Co | 0.01% | No change | 36,870 | $732K |
| Arax Advisory Partners | 0.05% | Add +7.0% | 23,917 | $475K |
| Jane Street Group, LLC | 0.00% | New | 14,768 | $293K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,405 | $28K |
| Harbour Investments, Inc. | 0.00% | Reduce -52.1% | 1,302 | $26K |
| Bank of Montreal | 0.00% | New | 400 | $9K |
| UBS Group AG | 0.00% | Reduce -33.7% | 63 | $1K |
"% of holder's portfolio" is MDEV's weight in each manager's 13F, not the share of First Trust Indxx Meddev the manager owns.